PLG and blood coagulation disease: These data reinforce the principle that prompt inhibition of plasmin-mediated fibrinolysis can limit ongoing bleeding before coagulopathy worsens [113], while also highlighting the importance of rapid administration (ideally within 3 h) and careful patient selection to maximise survival benefits and minimise risks [113,114,115].